Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | METAP2 | P50579 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 6/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 2/20 | 0.44 |
| ▸ | PLK4 | O00444 | 1/20 | 0.44 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.44 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | CSF1R | P07333 | 1/20 | 0.44 |
| ▸ | RET | P07949 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6066755 | 0.93 | KDM4E (0.48) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL7093585 | 0.91 | ALDH1A1 (0.50) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL402013 | 0.90 | BCAT2 (0.56) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL11218560 | 0.89 | ALDH1A1 (0.50) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL11215370 | 0.89 | ALDH1A1 (0.45) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL1512043 | 0.85 | MMP2 (0.47) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL698805 | 0.85 | KDM4E (0.64) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL2411340 | 0.84 | ALDH1A1 (0.55) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL8844181 | 0.84 | ALDH1A1 (0.50) | KDM4EALDH1A1MAPTTSHRHSD17B10 | |
| SCHEMBL5608858 | 0.84 | BCAT2 (0.61) | KDM4EALDH1A1MAPTTSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534627-B2 | Polymer particles and related additive manufacturing methods | XEROX CORPORATION (US) | 2026-01-27 | — | — | US | claimed |
| US-20250206932-A1 | LIVING HINGE OF AN ALPHA-NUCLEATED PROPYLENE COPOLYMER | BOREALIS AG (AT) | 2025-06-26 | — | — | US | claimed |
| US-20250163256-A1 | NUCLEATED BIMODAL POLYPROPYLENE | BOREALIS AG (AT) | 2025-05-22 | — | — | US | claimed |
| CN-118973917-A | Living hinge for alpha-nucleated propylene copolymers | 博里利斯股份公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118749009-A | Nucleated bimodal polypropylene | 博里利斯股份公司 | 2024-10-08 | — | — | CN | claimed |
| EP-4249388-B1 | LIVING HINGE OF AN ALPHA-NUCLEATED PROPYLENE COPOLYMER | BOREALIS AG (AT) | 2024-06-19 | — | — | EP | claimed |
| US-20240084149-A1 | POLYMER PARTICLES AND RELATED ADDITIVE MANUFACTURING METHODS | XEROX CORPORATION (US) | 2024-03-14 | — | — | US | claimed |
| US-11859103-B2 | Polymer particles and related additive manufacturing methods | XEROX CORPORATION (US) | 2024-01-02 | — | — | US | claimed |
| US-11739202-B2 | Bimodal polypropylene random copolymer with improved gamma-irradiation resistance | BOREALIS AG (AT) | 2023-08-29 | — | — | US | claimed |
| WO-2023117789-A1 | HIGH IMPACT POLYPROPYLENE COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2023-06-29 | — | — | WO | claimed |
| WO-2007120147-A1 | ARTICLES FROM PLASTICIZED THERMOPLASTIC POLYLEFIN COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-25 | — | — | WO | claimed |
| US-20070060508-A1 | Binding molecules | APLAGEN GMBH (DE) | 2007-03-15 | — | — | US | claimed |
| US-20060189744-A1 | Articles from plasticized thermoplastic polyolefin compositions | EXXONMOBIL CHEMICAL PATENTS, INC. | 2006-08-24 | — | — | US | claimed |
| JP-2006513980-A | — | — | 2006-04-27 | — | — | JP | claimed |
| EP-1527096-A2 | BINDING MOLECULES | AplaGen GmbH (DE) | 2005-05-04 | — | — | EP | claimed |
| EP-1394180-A1 | Synthetic mimetic molecules of physiological binding molecules | AplaGen GmbH (DE) | 2004-03-03 | — | — | EP | claimed |
| WO-2004014951-A2 | BINDING MOLECULES | APLAGEN GMBH (DE) | 2004-02-19 | — | — | WO | claimed |
| JP-2004502669-A | — | — | 2004-01-29 | — | — | JP | claimed |
| EP-1353898-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | claimed |
| WO-2002002512-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-01-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060508-A1 | Binding molecules | CD74, CLTB, CD2BP2 | KDM4E 4747/4885ALDH1A1 2322/4885MAPT 4204/4885 |
| US-12534627-B2 | Polymer particles and related additive manufacturing methods | LSM12, SMC3, LSM8 | KDM4E 2471/4885ALDH1A1 4241/4885MAPT 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.